RBCL (RBC Life Sciences) Cyclically Adjusted PS Ratio: (As of Jul. 12, 2026)


What is RBC Life Sciences Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


RBC Life Sciences  (OTCPK:RBCL) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


RBC Life Sciences Cyclically Adjusted PS Ratio Related Terms


RBC Life Sciences Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for RBC Life Sciences's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RBC Life Sciences Cyclically Adjusted PS Ratio Chart

RBC Life Sciences Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

RBC Life Sciences Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

RBCL vs SKVI, TISUQ, TECR: Cyclically Adjusted PS Ratio Comparison

For the Household & Personal Products subindustry, RBC Life Sciences's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RBC Life Sciences Cyclically Adjusted PS Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, RBC Life Sciences's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where RBC Life Sciences's Cyclically Adjusted PS Ratio falls into.



RBC Life Sciences Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

RBC Life Sciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2017 is calculated as:

For example, RBC Life Sciences's adjusted Revenue per Share data for the three months ended in Jun. 2017 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2017 (Change)*Current CPI (Jun. 2017)
=2.593/244.9550*244.9550
=2.593

Current CPI (Jun. 2017) = 244.9550.

RBC Life Sciences Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200709 3.446 208.490 4.049
200712 3.085 210.036 3.598
200803 2.813 213.528 3.227
200806 3.002 218.815 3.361
200809 4.332 218.783 4.850
200812 3.209 210.228 3.739
200903 2.745 212.709 3.161
200906 3.007 215.693 3.415
200909 2.959 215.969 3.356
200912 2.583 215.949 2.930
201003 3.135 217.631 3.529
201006 3.501 217.965 3.935
201009 2.726 218.439 3.057
201012 3.194 219.179 3.570
201103 2.901 223.467 3.180
201106 3.323 225.722 3.606
201109 3.176 226.889 3.429
201112 3.309 225.672 3.592
201203 2.730 229.392 2.915
201206 2.941 229.478 3.139
201209 3.020 231.407 3.197
201212 2.623 229.601 2.798
201303 2.560 232.773 2.694
201306 3.011 233.504 3.159
201309 2.995 234.149 3.133
201312 2.914 233.049 3.063
201403 2.583 236.293 2.678
201406 3.565 238.343 3.664
201409 3.397 238.031 3.496
201412 3.236 234.812 3.376
201503 2.423 236.119 2.514
201506 2.799 238.638 2.873
201509 2.444 237.945 2.516
201512 3.347 236.525 3.466
201603 2.348 238.132 2.415
201606 2.707 241.018 2.751
201609 3.311 241.428 3.359
201612 3.279 241.432 3.327
201703 2.577 243.801 2.589
201706 2.593 244.955 2.593

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


RBC Life Sciences Business Description

Address 2301 Crown Court, Irving, TX, USA, 75038
RBC Life Sciences Inc, through its subsidiaries, is engaged in marketing and distribution of nutritional supplements and personal care products. Its products include herbal formulas, vitamins, minerals, antioxidants, and skin, hair and body care products. It also markets its Nutritional Products in certain international markets through license arrangements. In addition to its Nutritional Products, the company also markets a line of wound care products under the MPM Medical brand name through a U.S. subsidiary.